(Q33565842)

28 July 2017

title

Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS. (English)

1 reference

28 July 2017

0 references

Luisa M Villar

1

0 references

author name string

María C Sádaba

2

1 reference

28 July 2017

Ernesto Roldán

3

1 reference

28 July 2017

Jaime Masjuan

4

1 reference

28 July 2017

Pedro González-Porqué

5

1 reference

28 July 2017

Noelia Villarrubia

6

1 reference

28 July 2017

Mercedes Espiño

7

1 reference

28 July 2017

José A García-Trujillo

8

1 reference

28 July 2017

Alfredo Bootello

9

1 reference

28 July 2017

José C Alvarez-Cermeño

10

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

Journal of Clinical Investigation

28 July 2017

published in

1 reference

28 July 2017

volume

115

1 reference

28 July 2017

issue

1

1 reference

28 July 2017

page(s)

187-194

1 reference

Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis.

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=539201

Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=539201

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=539201

Origins and functions of B-1 cells with notes on the role of CD5

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=539201

Role of natural and immune IgM antibodies in immune responses

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=539201

Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=539201

B cells and antibodies in CNS demyelinating disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=539201

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=539201

The role of B cells and autoantibodies in multiple sclerosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=539201

Pathogenesis of tissue injury in MS lesions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=539201

The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=539201

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=539201

The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=539201

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=539201

Lipid composition of the normal human brain: gray matter, white matter, and myelin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=539201

Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=539201

Central nervous system myelin: structure, function, and pathology

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=539201

B cells expressing CD5 are increased in cerebrospinal fluid of patients with multiple sclerosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=539201

CSF myelin basic protein, IgG and IgM levels in 101 MS patients before and after treatment with high-dose intravenous methylprednisolone

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=539201

Antibody-mediated CNS demyelination II. Focal spinal cord lesions induced by implantation of an IgM antisulfatide-secreting hybridoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=539201

Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=539201

Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=539201

A sensitive and reproducible method for the detection of oligoclonal IgM bands

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=539201

Antisulfatide antibodies in neuropathy: clinical and electrophysiologic correlates

31 October 2018

1 reference

12 December 2020

The Membrane Attack Complex of Complement Causes Severe Demyelination Associated with Acute Axonal Injury

1 reference

12 December 2020

Cutting edge commentary: two B-1 or not to be one

1 reference

12 December 2020

Antiganglioside antibodies in multifocal acquired sensory and motor neuropathy

1 reference

12 December 2020

Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis

1 reference

12 December 2020

Intrathecal IgM synthesis in neurologic diseases: Relationship with disability in MS

1 reference

12 December 2020

An ultrasensitive method for the detection of oligoclonal IgG bands

1 reference

12 December 2020

Transition in CD45 isoform expression during differentiation of normal and abnormal B cells

1 reference

12 December 2020

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

12 December 2020

CD1b is expressed in multiple sclerosis lesions

1 reference

12 December 2020

Lymphocyte subsets in multiple sclerosis. A study with two-colour fluorescence analysis

1 reference

12 December 2020

MBP, anti-MBP and anti-PLP antibodies, and intrathecal complement activation in multiple sclerosis

1 reference

12 December 2020

Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group

1 reference

12 December 2020

Identifiers

DOI

10.1172/JCI22833

1 reference

28 July 2017

1 reference

28 July 2017

1 reference